Viral infections are often localized to specific cells and tissues within the host. This cell and tissue tropism results in distinct disease patterns for different viruses. Because all viruses initiate infection by binding to a specific receptor on the cell surface, the virus-receptor interaction has long been considered the first determinant of tissue tropism. For some viruses, such as human immunodeficiency virus type 1 (18) and Epstein-Barr virus (1) , expression of cell receptors appears to control the pattern of virus infection in the host. However, viral replication in the host may be blocked at steps in the viral life cycle other than receptor binding. For example, the receptor for influenza virus, sialic acid, is ubiquitous, yet viral replication is largely limited to the respiratory tract. Influenza virus tropism is most likely determined by the availability of cellular proteinases required for cleavage of the hemagglutinin (8; reviewed in reference 27).
Poliovirus, the causative agent of paralytic poliomyelitis, is a human enteric virus that is classified into three serotypes. Most polioviruses have a distinct species tropism and only infect primates (reviewed in reference 21). In the primate host, poliovirus infection is characterized by a restricted tissue tropism; poliovirus replicates only in the pharynx and gut and in neurons within certain regions of the central nervous system (CNS), despite the presence of virus in many organs during the viremic phase of infection (3, 26) . The molecular basis for this restricted tropism is not known. Assays for virus binding activity in tissue homogenates revealed a correlation between poliovirus binding and susceptibility to poliovirus infection (9) . However, virus has also been reported to bind homogenates of tissues that are not sites of poliovirus replication (9, 17) .
A human cell receptor for poliovirus (PVR) has recently been identified as a novel member of the immunoglobulin superfamily of proteins (19) . PVR RNA and protein are * Corresponding author.
expressed in a wide range of human tissues, including those that are not sites of poliovirus infection (7, 19) . However, little is known about PVR gene expression in individual cell types. It is possible that cells expressing PVR within nonsusceptible tissues are not accessible to poliovirus, or perhaps only a small fraction of cells in these tissues express PVR and as a result virus growth is not detected. Restriction of PVR expression to neurons within the brain and spinal cord might explain the selective vulnerability of these cells to poliovirus infection. Alternatively, poliovirus tissue tropism may not be governed solely by expression of PVR but may depend on tissue-or cell-specific modification of the PVR, additional factors required for PVR function, or perhaps factors required for subsequent stages in virus replication.
We previously established transgenic mice containing the human PVR gene in the germ line (PVR transgenic mice) (24) . The transgenic mice express PVR transcripts and poliovirus binding sites in a wide range of tissues. Inoculation of PVR transgenic mice with poliovirus leads to development of a fatal paralytic disease that clinically and histopathologically resembles human poliomyelitis. Absence of PVR is therefore the determinant of poliovirus host range restriction in mice. To characterize the tropism of poliovirus infection in PVR transgenic mice, the location of poliovirus replication in infected animals was determined by in situ hybridization and compared with the distribution of PVR transcripts in different cell types. Within the brain and spinal cord, PVR transcripts and poliovirus replication were detected only in neurons. However, despite the expression of PVR transcripts in specific cell types of many nonneural tissues, the only other site of poliovirus replication detected was skeletal muscle. Transgenic mouse kidney, which expresses PVR transcripts and virus binding sites but is not susceptible to poliovirus infection, developed permissivity to infection after cultivation in vitro, providing a model for studying the mechanism of resistance to poliovirus infection.
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MATERIALS AND METHODS
Hybridization probe synthesis. A 1,263-bp SmaI-XhoI fragment of PVR cDNA H20B, which contains most of the PVR coding sequences, was subcloned into plasmid vector pBluescript KS(-) and designated pBS5R. For in situ hybridization, antisense probes labeled with [35S]UTP to a specific activity of 2 x 106 to 4 x 106 cpm/ng were generated by using BamHI-digested pBS5R as template for transcription by T3 RNA polymerase. Alternatively, the control sense strand was synthesized with XhoI-digested pBS5R template and T7 polymerase. Similarly, the 1,452-bp BgIIIPvuII fragment of poliovirus type 1 Mahoney (P1/Mahoney) cDNA, containing poliovirus polymerase coding sequences, was subcloned into plasmid vector pBluescript KS(-) and designated pBSMP. Antisense probe was generated by using SacI-digested pBSMP and T3 polymerase, and sense probe was synthesized from Clal-digested pBSMP by T7 polymerase. The RNA was hydrolyzed at pH 10.2 at 60°C, as described previously (11) , to yield probes approximately 100 bp in length. Probe length before and after hydrolysis was assessed on formaldehyde-agarose gels.
In situ hybridization. Mice were sacrificed, and the brain, spinal cord, thymus, lung, intestine, spleen, kidney, adrenal gland, and hindlimb muscle were removed and fixed by overnight immersion in 4% paraformaldehyde at 4°C. The paraformaldehyde was replaced with phosphate-buffered saline (PBS), and tissues were washed, dehydrated, and embedded in paraffin wax as described previously (11) . Embedded tissues were sectioned at 6 p.m and collected on Tespa-treated slides. Hybridization, exposure to photoemulsion (3 to 6 days for PVR probes and 1 day for poliovirus probes), counterstaining, and microphotography were as described previously (11) . Positive hybridization was determined by comparison with background levels, defined by using sense probes on transgenic mouse sections and antisense probes on nontransgenic mouse sections.
Cells, virus, and mice. Mice were sacrificed, and the kidneys were removed, washed three times with Dulbecco's modified Eagle's medium (DMEM) (GIBCO), and sliced into small pieces. The tissue slices were then treated with 10 mg of collagenase H (Boehringer Mannheim Biochemicals) per ml that had been dissolved in DMEM and sterile filtered for 3 h at 37°C. The suspension was centrifuged at room temperature at 1,000 x g for 10 min. The cell pellet was resuspended in 10 ml of enzyme-free cell dissociation solution (Specialty Media, Inc.), incubated at 37°C for 15 min and centrifuged at 1,000 x g for 10 min. The cell pellet was either resuspended in DMEM containing 10% fetal bovine serum, 100 U of penicillin per ml, 100 ,ug of streptomycin per ml, and 10 p.g of gentamicin per ml for culture in monolayers or cultured in suspension as described previously (23) . For culture in monolayer, the cells were placed in 25-cm2 tissue culture flasks pretreated with 0.5% gelatin at 37°C overnight.
HeLa S3 cells were grown in monolayer as described previously (23) . P1/Mahoney strain was derived from the infectious cDNA clone (22) . Three-week old mice of the PVR transgenic line TgPVR1-17 (24) were used for all experiments.
Virus growth and assay. Monolayers and suspension cultures of transgenic mouse kidney cells were infected with P1/Mahoney at a multiplicity of infection of 10. After 60 min of adsorption, the plates were washed three times to remove unattached viruses and the medium was replaced. Aliquots of the supernatant were removed at different times after infection, and virus titers were determined by plaque assay on HeLa cell monolayers. Tenfold serial dilutions of viruses, prepared in PBS plus 0.2% horse serum, were used to inoculate 6-cm dishes of HeLa cells and adsorbed at 37°C. The cells were then covered with 5 ml of 0.9% Bacto-Agar (Difco Laboratories) in DMEM plus 5% horse serum. After incubation at 37°C in 5% CO2 for 2 to 3 days, plates were stained with crystal violet as described previously (23) .
For virus binding assay, dispersed kidney cells from approximately 50 mg of fresh kidney were mixed with 106 PFU of P1/Mahoney and incubated at 37°C for 2 h. Cells were removed by centrifugation, and the remaining infectious virus in the supernatant was determined by plaque assay. Percent binding was calculated by subtracting the amount of virus remaining in the supernatant from the input virus, determined after mock incubation in PBS. Results are the average of two experiments.
PCR ampiffication of cDNA. Preparation of total cell or tissue RNA and oligo(dT)-primed cDNA synthesis was as described previously (19) . Quantitative polymerase chain reaction (PCR) amplification of cDNA was carried out as described previously (29) , using PVR-specific primers flanking the transmembrane domain (nucleotides 1170 to 1191 and 1422 to 1443; numbered as in reference 19).
RESULTS
Localization of PVR RNA in transgenic mouse tissues.
Previous analysis of PVR gene expression by Northern (RNA) blot hybridization showed that PVR transcripts are expressed at different levels in a wide range of transgenic mouse organs (24) . High-stringency in situ hybridization with radiolabeled PVR RNA probes was used to examine the distribution of PVR RNA in specific cell types.
Expression of the PVR in transgenic mouse CNS was examined by hybridizing transverse sections of adult spinal cord and sagittal sections of the brain with antisense PVR RNA probes. Most neurons in all areas of the CNS expressed high levels of PVR transcripts ( Fig. 1F to H). All neurons in the spinal cord, including motor and autonomic neurons and interneurons, expressed high levels of PVR RNA. In the brain, PVR RNA was detected in neurons of all cortical layers of the cerebral cortex and cerebellum and in nuclei of the brain stem, hippocampus, thalamus, hypothalamus, amygdala, pyriform cortex, basal ganglia, and olfactory bulb. The signals observed in spinal cord neurons were consistently higher than those observed in the brain. Within the brain, high levels of PVR transcripts were detected in neurons of the cerebral cortex and brain stem, in pyramidal cell layers of the hippocampus and pyriform cortex, and in amygdala, the mitral cell layer of the olfactory bulb, and the anterior olfactory nucleus (Fig. 1H) . Neurons in the peripheral nervous system, such as parasympathetic ganglia, also showed high levels of expression (25) .
In the kidney, high levels of PVR transcripts were detected in epithelial cells of the parietal layer of Bowman's capsule, possibly also in podocytes (the visceral layer of Bowman's capsule) in the glomerulus, and in some tubular epithelial cells in the medulla, predominantly in the outer stripe of the outer zone and the renal papilla ( Fig. la and b) . PVR transcripts were not detected in the renal pelvis, nor in lymph nodes, fatty tissue, or blood vessels that surround the kidney.
In the lung, PVR transcripts were detected in cells, tentatively identified as macrophages, lining the alveoli ( Fig. lc and d ). PVR gene expression was detected at low levels in most cells of the intestine, spleen, and skeletal muscle (25) .
Alternatively spliced forms of PVR transcripts have been described that encode two soluble forms of PVR that lack the transmembrane domain (15) . Transcripts encoding both membrane-bound and soluble PVR were detected in all organs tested of another line of PVR transgenic mice (16) . Using PCR amplification of cDNA, PVR RNA encoding membrane-bound PVR and two soluble forms of PVR was detected in all organs examined in the PVR transgenic mice studied here. For example, all three forms were detected in brain and kidney, as well as in HeLa cells (Fig. 2) . Nucleotide sequence analysis of PCR products indicated that the alternatively spliced forms are identical to those reported previously (15) .
Poliovirus replication sites in the CNS of transgenic mice. To identify the sites of virus multiplication in the CNS, mice were infected intraperitoneally or intracerebrally and tissues of paralyzed animals were examined by in situ hybridization with viral RNA probes.
In paralyzed transgenic mice, spinal cord lesions were the most severe in the neuraxis, with inflammation and neuronal degeneration localized largely to the ventral horns. Infected neural cells were detected by in situ hybridization in all areas of the grey matter, including the ventral horn, intermediate and intermediolateral columns, and dorsal horn (Fig. 3) . Viral RNA was detected in the cytoplasm of neurons, both in the cell bodies and in their axonal and dendritic processes. Diffuse hybridization was often observed around lysed neurons in areas containing inflammatory cells (Fig. 3a) amplified by quantitative PCR of cDNA, using 5' 32P-labeled primers flanking the PVR transmembrane region, and fractionated on a 6% polyacrylamide gel. Total RNA (10, 5, or 2.5 ,ug) was used for cDNA synthesis and/or amplification. Size markers (m) of 123 and 246 bp are indicated. Lane p, products of PCR, using PVR cDNA as template. The positions of amplified products from H20A, H20AA1, and H20AA&2 are shown; nucleotide sequence analysis confirmed that these are derived from mRNAs encoding membrane-bound PVR and two soluble forms of PVR. H20AA2 products are visible in tissues after long exposure of the autoradiograph.
neurons in these regions were not susceptible to poliovirus or whether virus was unable to reach these areas after intraperitoneal inoculation. To address this question, transgenic mice were infected intracerebrally and brains from paralyzed mice were examined by in situ hybridization (Fig.  4) . The results indicated that neurons in the brain stem were extensively infected, and viral replication was also detected in neurons in many other areas of the brain, including the cerebral cortex, pyramidal layer of the hippocampus, olfactory bulb, thalamus, hypothalamus, and deep cerebellar nuclei.
Poliovirus susceptibility of transgenic mouse nonneural tis- the ability of poliovirus to replicate in kidney and thymus was determined. PVR transgenic mice were inoculated intravenously with 106 PFU of P1/Mahoney, and at different times after infection organs were removed and homogenized, and virus titer was determined by plaque assay. Virus titer in both kidney and thymus declined within the first 3 (25) . Poliovirus also failed to replicate in liver and spleen after intravenous inoculation and in the intestine after oral inoculation (25). However, it was possible that the inoculated virus did not have the opportunity to infect susceptible cells, because virus in the blood is quickly removed by the reticuloendothelial system (26) . To examine this possibility, transgenic mice were inoculated intraperitoneally with 5 x 107 PFU of P1/Mahoney and virus levels in kidney were determined by plaque assay. Virus titers in both transgenic and nontransgenic kidney declined rapidly after inoculation, and no virus was detected in this organ after day 2 postinfection (Fig. 6) . Paralysis was observed in many of these animals, indicating that virus had reached the CNS. Because only a small fraction of kidney cells express PVR, virus growth in these cells might not be detected by plaque assay of kidney homogenates. Therefore, poliovirus replication in transgenic mouse kidney and surrounding tissues was examined by in situ hybridization, using an antisense viral RNA probe. Viral replication was not detected in kidney, adrenal gland, connective tissue, fatty tissue, lymph node, parasympathetic ganglia, blood cells, or blood vessels for 1 week after intraperitoneal inoculation, although paralytic disease developed in some of these animals (25) .
Susceptibility of cultured PVR transgenic mouse kidney cells to poliovirus. Although poliovirus tropism in primates is restricted, cells from almost any tissue become susceptible to poliovirus infection after cultivation in vitro (6, 9, 13) . To examine the susceptibility of cultured PVR transgenic mouse kidney cells to poliovirus, kidneys were dispersed with collagenase and cultivated either in monolayers or in suspension and infected with poliovirus at a multiplicity of infection of 10. Although freshly isolated transgenic mouse kidney cells were resistant to poliovirus infection, after 24 h of growth in culture, the cells became highly susceptible to poliovirus infection (Table 1 The results show that PVR RNA is expressed at a high level in neurons of both the central and peripheral nervous systems, in T lymphocytes in the thymus, in epithelial cells of Bowman's capsule and some tubules in the kidney, possibly in alveolar macrophages in the lung, and in endocrine cells in the adrenal cortex. High-level PVR RNA expression was not detected in intestine, spleen, and lymph nodes. Although PVR expression was widespread, when transgenic mice were inoculated with poliovirus, viral replication was limited to skeletal muscle and the CNS. Poliovirus RNA was detected in muscle cells of the hamstring after intramuscular inoculation. In addition, we have recently obtained evidence that poliovirus replicates in the muscles of transgenic mice after oral administration of virus (25) . Replication of poliovirus has also been demonstrated in monkey skeletal muscle after intramuscular inoculation (28) . Poliovirus RNA was detected in all neurons of the spinal cord and in most neurons in the brain stem. In the brain, infected neurons were detected in several areas, including the cerebral cortex, pyramidal layer of the hippocampus, olfactory bulb, thalamus, hypothalamus, and deep cerebellar nuclei. Poliovirus replication was not detected in kidney, adrenal gland, thymus, and intestine. Susceptibility of cells to poliovirus therefore appears to correlate with PVR RNA expression in the CNS and in muscle, but not in other tissues.
There are several possible explanations for the failure of poliovirus to replicate in transgenic mouse tissues that express the PVR. It is unlikely that PVR transcripts detected by in situ hybridization are not translated. Organ homogenates from PVR transgenic mice contain poliovirus binding activity (24) , and freshly dispersed transgenic mouse kidney cells express the PVR on the cell surfaces, as shown by their ability to bind poliovirus. Virus may be unable to reach some cells which express PVR RNA, such as developing T lym-VOL. 66, 1992 phocytes of the thymus and epithelial cells of Bowman's capsule. However, tubular epithelial cells in the kidney and endocrine cells in the adrenal cortex should be exposed to circulating viruses. Poliovirus replication was not detected in these cells, indicating that poliovirus tissue tropism is not governed solely by expression of the PVR gene nor by accessibility of cells to virus.
Alternative splicing of PVR transcripts might control susceptibility of tissues to poliovirus infection. Human tissues contain both membrane-bound and secreted PVR isoforms, generated by alternative splicing of PVR mRNA (15) . Expression of secreted PVRs in transgenic mouse tissues might result in neutralization of poliovirus infectivity (14) . The results presented here, together with observations made with another PVR transgenic mouse line (16) , reveal that RNAs encoding both membrane-bound and secreted PVRs are present in susceptible and nonsusceptible tissues, as is found in human tissues (15) . These results, together with our observation that dispersed kidney cells in culture (from which soluble PVR would have been removed by washing) are still resistant to poliovirus infection, support the idea that secreted PVRs are not likely to restrict poliovirus in vivo. Alternatively, virus binding to nonsusceptible tissues might be blocked in vivo by the natural ligand of the PVR, or poliovirus entry might require factors in addition to the PVR that are lacking in nonsusceptible tissues. For example, expression of human CD4 in rodent cells is not sufficient to render these cells susceptible to human immunodeficiency virus type 1 infection because of a block at the level of entry (18) .
Poliovirus replication in nonsusceptible tissues might be controlled at stages beyond virus entry, such as translation, replication, or assembly. This possibility has been generally discounted in the past, because inoculation of viral RNA intracerebrally into rabbits, chicks, guinea pigs, and hamsters results in one cycle of replication and production of infectious virus (10) . However, these experiments indicate only that poliovirus host range restriction (species tropism) is determined at the level of entry in neural cells. Whether there is an internal block to poliovirus infection in nonsusceptible tissues remains unresolved. This question is being addressed by determining whether introduction of viral RNA into fresh dispersed kidney cells leads to poliovirus replication.
Although poliovirus infection in primates is restricted, cells from almost any tissue develop susceptibility to infection after cultivation in vitro (6, 9, 13) . PVR transgenic mouse kidney cells express poliovirus binding sites but are initially resistant to poliovirus infection. When cultured in vitro, kidney cells develop susceptibility to poliovirus infec-1 . (2, 12) , and PVR has been detected in a small percentage of freshly dispersed endothelial cells (5) . These observations suggest that poliovirus may use receptors on endothelial cells to gain access to the CNS from capillaries. However, neither PVR expression nor virus replication was detected in endothelial cells of several PVR transgenic mouse organs, including the CNS. Poliovirus spread in transgenic mice is therefore not likely to involve receptors on endothelial cells. The presence of poliovirus RNA in axonal and dendritic processes of neurons suggests that virus could spread though neural pathways. In support of this hypothesis, preliminary data suggest that poliovirus spreads to the spinal cord through peripheral nerves after intramuscular inoculation of PVR transgenic mice (25) .
An important question is whether studying poliovirus tropism in PVR transgenic mice provides information on tropism of the virus in primates. The pattern of expression of many human genes in transgenic mice is often similar to that observed in humans (reviewed in reference 20). Indeed, in both PVR transgenic mice (24) and humans (7, 19) , the PVR gene is expressed in many tissues, suggesting that PVR expression in transgenic mice may mimic that in humans. One difference, however, is that poliovirus binding sites are expressed in all PVR transgenic mouse tissues examined (24) , whereas binding sites in humans have been detected largely in neural tissues and intestine and occasionally in kidney and liver (9, 17) . It is possible that the basis of poliovirus tropism in humans differs from that in PVR transgenic mice and is determined by factors that control the ability of the receptor to bind virus. Alternatively, poliovirus binding sites might be expressed in all human tissues, but at low levels or in unstable forms, making their detection difficult in some tissues. The PVR transgenic mice studied to date contain multiple copies of the PVR gene and express high levels of PVR mRNA, perhaps facilitating detection of binding sites in all organs. Resolution of this question awaits examination of PVR gene expression in human tissues by in situ hybridization for comparison with that in PVR transgenic mice and development of more-sensitive assays to detect poliovirus binding sites in human tissues. Preliminary results indicate that PVR expression in human placenta is restricted to specific cell types, suggesting that PVR in humans is expressed in a'cell-specific pattern (25) . It will be of interest to use PVR transgenic mice to determine how PVR gene expression is regulated in a cell-type-specific manner.
